Abstract P2X receptors are cation-permeable ion channels gated by extracellular adenosine triphosphate (ATP). Available crystallographic data suggest that ATP-binding ectodomain is connected to the transmembrane pore domain by three structurally conserved linker regions, which additionally frame the lateral fenestrations through which permeating ions enter the channel pore. The role of these linker regions in relaying the conformational change evoked by ATP binding of the ectodomain to the pore-forming transmembrane domain has not been investigated systematically. Using P2X 4 R as our model, we employed alanine and serine replacement mutagenesis to determine how the side chain structure of these linker regions influences gating. The mutants Y54A/S, F198A/S, and W259A/S all trafficked normally to the plasma membrane of transfected HEK293 cells but were poorly responsive to ATP. Nevertheless, the function of the F198A/S mutants could be recovered by pretreatment with the known positive allosteric modulator of P2X 4 R, ivermectin (IVM), although the IVM sensitivity of this mutant was significantly impaired relative to wild type. The functional mutants Y195A/S, F200A/S, and F330A/S exhibited ATP sensitivities identical to wild type, consistent with these side chains playing no role in ATP binding. However, Y195A/S, F200A/S, and F330A/S all displayed markedly changed sensitivity to the specific effects of IVM on current deactivation, suggesting that these positions influence allosteric modulation of gating. Taken together, our data indicate that conserved amino acids within the regions linking the ectodomain with the pore-forming transmembrane domain meaningfully contribute to signal transduction and channel gating in P2X receptors.
Introduction
P2X receptors (P2XRs) are ligand-gated nonselective cation channels activated by extracellular adenosine triphosphate (ATP) [1] and composed of seven receptor subunits (P2X 1 -7 ) that associate, as either homo-or heterotrimeric channels [2] . These receptors play important roles in the nervous system [3] , in which they can mediate and modulate fast synaptic transmission [4] [5] [6] [7] [8] . Different subtypes distribute differently as P2X 4 Rs are widely expressed in the superior cervical ganglion, brain, hippocampus, and pancreatic islet cells [9] [10] [11] [12] .
Several P2XR-targeted drugs may play roles in the regulation of different P2XRs. The macrocylic lactone ivermectin (IVM) has been shown to potentiate ATP-gated currents mediated by P2X 4 R [13] and, more recently, the human form of P2X 7 R [14] . In clinical medicine, IVM is widely used in humans and animals as an antihelmintic agent for the treatment of parasitic diseases such as onchocerciasis (river blindness) [15] . Here, IVM causes membrane hyperpolarization and muscle paralysis [16] by activating glutamate-gated chloride channels in the nerves and muscles of the parasite. IVM has dramatic effects on the ATP-activated current of P2X 4 R. The ATP-activated currents of P2X 4 R are dramatically affected by IVM, which increases the maximal current amplitude in the presence of saturating ATP and slows the rate of current deactivation after washout of ATP [13] .
In common with all P2XRs, each functional P2X 4 R homomer is comprised of three subunits, with each subunit containing two transmembrane domains, intracellular -NH 2 and -COOH termini, and a large ectodomain [2] . The ectodomain can be divided into the upper vestibule, the central vestibule, and the extracellular vestibule, the latter of which lies directly adjacent to the pore-forming transmembrane domain [17] . The ectodomain is connected to the transmembrane domain by three linker regions that also serve to frame three fenestrations that are now known to be the primary point of access for ions into the extracellular vestibule and pore domain ( Fig. 1a and b ) [18] [19] [20] [21] . The positioning of these linker regions between the ligand-binding ectodomain and the poreforming transmembrane domain favor their playing a key role in signal transduction and channel gating, and yet despite this, there has been no direct effort to determine confirms this. A number of bulky side chain-bearing residues are present in the linker regions that are conserved throughout the P2XR family, including Tyr Fig. 1a and b) . We predicted that these might be important in stabilizing the interaction between the ectodomain and pore-forming domain and that reduction of side chain volume by substitution to alanine or serine might be expected to retard signal transduction and gating of the P2X 4 R channel. Furthermore, based on previous evidence that residues lining the fenestrations regulated IVM sensitivity in P2X 4 [18] , we predicted that the allosteric effects of this drug on P2X 4 R gating might be impacted by amino acid substitutions introduced into this region. Thus, we studied the effects of these mutants on the ATP-induced current in both the absence and the presence of IVM.
Materials and methods
Channel constructs Rat P2X 4 (rP2X 4 ) clones were kindly provided by Dr. Terrance M. Egan (Saint Louis University). The rat P2X 4 receptor construct was used as a template for the production of plasmids containing mutations of conserved aromatic residues to alanine and serine. Point mutations were introduced using the KOD-Plus-Mutagenesis Kit (TOYOBO, Japan) according to the manufacturer's instructions. Primers for cloning and mutagenesis were synthesized by Invitrogen (Life Technologies, USA). The phenylalanine residues at positions 198, 200, and 330; the tyrosine residues at positions 54 and 195; and the tryptophan residue at position 259 were mutated to alanine and serine. The production of the correct mutations and the absence of coding errors in the P2X 4 mutant constructs were verified by DNA sequencing (Automated ABI Sequencing Service, Life Technologies, USA). cDNAs were propagated in Escherichia coli DH5α, and the plasmids were purified using a TaKaRa MiniBest Plasmid Purification Kit (TaKaRa, Japan).
Cell culture and transfection Experiments were performed on human embryonic kidney 293 cells (HEK293 cells), which were grown in Dulbecco's modified Eagle's medium (D-MEM) supplemented with Glutamax (Invitrogen, USA), 10 % fetal bovine serum (HyClone, USA), 50 U/ml penicillin, and 50 μg/ml streptomycin in a humidified 5 % CO 2 atmosphere at 37°C. Cells treated with trypsin were cultured in sixwell plates for 24-48 h until reaching 60 %-80 % confluence before transfection. The expression vectors containing the cDNA for the wild-type and mutant P2X 4 receptors were transiently coexpressed together with enhanced green fluorescent protein in HEK293 cells using Effectence Transfection Reagent (QIAGEN, USA). The 4 μl of enhancer, 10 μl of effectence, 1 μg of P2X 4 receptor cDNA, and 1 μg of GFP cDNA were used for each transfection following the manufacturer's instructions. The plasmid encoding GFP was cotransfected to aid the visual identification of transfected cells for electrophysiological recording experiments. After 8 h of incubation, the transfection mixture was replaced with D-MEM and cultured for 24-48 h prior to whole-cell recording experiments.
Electrophysiological recordings Whole-cell currents were measured at room temperature from cells held at −60 mV using the perforated-patch, whole-cell, voltage-clamp technique. Whole-cell recordings were made with low-resistance (2−5 MΩ) borosilicate glass electrodes, which were pulled from borosilicate glass using a Flaming Brown Horizontal puller (P-97, Sutter Instruments, Novato, CA). The electrodes were filled with 200 μg/ml amphotericin B dissolved in an intracellular solution of the following composition (in mM): 130 Cs-methanesulfonate, 24 CsCl, 1 MgCl 2 , 1 CaCl 2 , and 10 HEPES. The dishes with cell cultures were continuously perfused with an extracellular solution of the following composition (in mM): 154 NaCl, 1 MgCl 2 , 1 CaCl 2 , 10 glucose, and 10 HEPES, adjusted to pH 7.3 with 1 M NaOH. All solutions were maintained at pH 7.3-7.4 and 300-328 mOsm/L. All chemicals were purchased from Sigma. In all experiments, solutions containing ATP or IVM were applied with a fast gravity-driven perfusion system consisting of an RSC-200 Rapid Solution Changer (Biologic, Claix, France). Movements of the glass tube array and solution application were controlled by protocols in the pClamp 10.0 software. Successive applications were separated by 2-5 min to minimize receptor desensitization. An Axonpatch 200B amplifier was controlled by pClamp 10.0 software via a Digidata 1440A interface board (Axon Instruments) for all recordings. Data were filtered at 2 kHz and digitized at 5 kHz.
Confocal microscopy Transiently transfected HEK293 cells with the wild-type (WT) receptor and its mutants were plated onto poly-L-lysine-coated coverslips. At 24 h after transfection, the cells were fixed for 15 min in ice-cold 4 % paraformaldehyde (pH 7.4), permeabilized with 0.5 % Triton X-100 in PBS for 15 min, and incubated in blocking buffer (1 % BSA, PBS pH 7.5) for 1 h to block nonspecific antibody binding. The cells were then incubated with blocking buffer containing primary antibody (anti-P2X 4 antibody, 1:1,000, Sigma, USA) at 4°C overnight or at room temperature for 2 h. Afterward, the cells were incubated with secondary antibody (Goat Anti-Rabbit IgG-HRP, 1:2000, sigma, USA) for 30 min at room temperature. Finally, the coverslips containing transfected cells were covered with anti-fade mounting medium (Beyotime, China) to prevent fluorescence fading. The localization of the receptors in cells was examined by laserscanning confocal microscopy (Zeiss 710 NLO, Germany). Images were collected using a 40× oil immersion objective.
Data analysis Dose-response data points were fitted by a Hill equation using a nonlinear curve-fitting program that calculated the EC 50 and Hill coefficient values of the resulting curves (SigmaPlot version 10.0, SPSS Inc.). ATP was repeatedly applied at 1-to 2-min intervals usually with the following sequence of concentrations, 0.3, 1, 10, 3, 10, 30, 10, and 100 μM. All responses were relative to the 1 or 10 μM response. The equation was
nH ], where y was the maximum amplitude of the current evoked by a given concentration of ATP (normalized in all cases), A 2 was the maximum current amplitude, A 1 was the minimum current amplitude, EC 50 was the agonist concentration that produced 50 % of the maximal response, n H was the Hill coefficient, and x was the concentration of ATP. Concentration−response relationships for the effects of IVM on potentiation and deactivation were fitted by a Hill equation (SigmaPlot version 10.0, SPSS Inc.) as follows,
nH +EC 50 nH }, where I IVM was I max in response to 10 μM ATP at a given concentration of IVM, I Ctrl was I max in response to 10 μM ATP in the absence of IVM or incubated in 0.1 μM IVM, a was the maximal fold increase in I max induced by IVM, [IVM] was the concentration of IVM, n H was the Hill coefficient, and EC 50 was the concentration of IVM that gave a half-maximal response. The kinetics of the current decay evoked by washing out the agonists was fitted to a two-exponential function [y=A 1 exp(−t/τ 1) +A 2 exp(−t/τ 2 )) using the program CLAMPFIT 10.2 (Axon Instruments), and the derived time constant was labeled τ off . A 1 and A 2 are the relative amplitudes of the first and second exponential, respectively, and τ 1 and τ 2 are the corresponding time constants. All the numerical values in the text are reported as the means± S.E.M. for n cells, and significant differences were determined by using Student's t test. The graphical representations of the protein structure were performed using PyMOL software (DeLano Scientific LLC, USA), and the models were got from the Brookhaven Protein Data Bank (4DW1 for the zfP2X 4 R in the ATP-bound open state and 4DW0 for the receptor in the apoclosed state).
Results ATP-and IVM-sensitivity of wild-type P2X 4 R Whole-cell current recordings from HEK293 cells expressing wild-type P2X 4 R were made during repetitive (every 3 min) stimulation with 2-s pulses of 10/100 μM ATP in the presence and absence of IVM. Consistent with other work [22] , we determined the EC 50 for ATP activation of P2X 4 R to be 5.7± 1.0 μM (Fig. 1c ). Also consistent with previous studies, IVM was observed to increase the amplitude of the ATPgated current and delay the deactivation time course after wash out of ATP [22] . In our hands, the peak amplitude of the ATP-induced current was increased approximately twofold in the presence of 3 μM IVM. We estimated the EC 50 for ATP activation in the presence of 3 μM IVM to be 1.2± 0.3 μM, representative of an approximately fivefold increase in ATP sensitivity. The deactivation time constant (τ off ) for the decline in ATP-gated current upon wash out of the drug was significantly prolonged after treatment with 3 μM IVM for 5 min (from τ off =0.4±0.02 s to 29±2.3 s).
Effect of linker region substitutions on ATP-dependent gating of P2X 4 R Scanning alanine-and serine-mutagenesis was employed to determine whether conserved aromatic residues in the linker regions connecting the ecto-and transmembrane domains were important for channel function. Alanine and serine substitutions were introduced at positions Tyr (Fig. 1b) . Whole-cell recordings were used to measure the channel activity after these mutants were transfected into HEK293 cells. Mutation of Tyr , and Phe 330 to both alanine and serine yielded functional receptors when expressed in HEK293 cells (Fig. 2a) . Consistent with these residues being located relatively distant from the ATP binding domain, their EC 50 s for ATP activation were not significantly different from wild type (Fig. 2b, Table 1 ). The mutants, Y54A/S, F198A/S, and W259A/S, were unresponsive to even high concentrations of ATP (up to 1-3 mM) (Fig. 2a, Table 1 ). To investigate whether this was due to an impairment of protein trafficking to the plasma membrane, we monitored the expression pattern of the mutants in HEK293 cells using immunofluorescence imaging (Fig. 3a) . Similar to the WT control, all three mutants demonstrated substantial plasma membrane localization, suggesting normal packaging and trafficking. Further evidence that these mutants were expressed on the plasma membrane was revealed with IVM, which successfully revealed ATP-gated currents for F198 mutants (Fig. 3b, c, d , and e).
Taken together, these results suggest that mutation of side chains in this region has a profound impact on ATP gating, as would be predicted given the positions of the linkers between the ligand binding and pore-forming domains. This conclusion is supported by three pieces of evidence. First, those mutants that were functional showed normal ATP EC 50 values. Second, not even very high concentrations of ATP could evoke currents through Y54A/S, F198A/S, and W259A/S mutants. Third, ATP-evoked currents could only be observed for F198A/S mutants after treatment with the known allosteric gating modulator, IVM.
Effect of linker region substitutions on IVM-sensitivity of P2X 4 R gating Our data suggested that one residue, Phe
198
, was important for normal P2X 4 R channel gating, and that two others, Tyr 54 and Trp
259
, might contribute also. Previous studies had shown that IVM-modulated P2X 4 R gating in the presence of ATP, and so we wished to test the hypothesis that mutation of residues in the linker regions might impact the sensitivity of the channel to such allosteric modulation. For the mutants F198A/S, we noted that the currents recovered in the presence of IVM had a much more rapid deactivation time course than the WT ATP-gated current in the presence of IVM. F198A/S exhibited a τ off of approximately 5.5±1.6/6.4±2.0 s, compared with 29±2.3 s for wild type (Fig. 3b, Table 1 ). The EC 50 of IVM effect on potentiation and deactivation of F198A/S (EC 50 =2.02±0.52/1.90±0.44 μM and 6.12±1.85/ 5.84±1.56 μM) showed rightward shift compared with wild type (EC 50 =0.23±0.05 μM and 2.16±0.45 μM) (Fig. 3d and e, Table 2 ), indicating a reduced IVM potency. The equivalent F198A mutant of P2X 1 receptor resulted in half peak current amplitude with no significant change in the ATP potency compared with wild type [23] . This result was similar to the effect found for Val 49 and Gly 29 in transmembrane domains [24] . All these results implied that Tyr We next looked at the mutants that produced functional channels with normal ATP EC 50 values, Y195A/S, F330A/ S, and F200A/S, to see if they exhibited different sensitivities to allosteric modulation by IVM. In the presence of 3 μM IVM, the deactivation time constant was significantly prolonged for two mutants, Y195A/S (τ off = 51 ± 2.4/54 ± 1.2 s) and F330A/S (τ off =40±4.9/47±4.5 s), and was reduced for F200A/S (τ off =10±3.9/10±4.4 s) compared with the wild type (τ off =29±2.3 s) ( Table 1 , Fig. 4a and b) .
Given that Y195A/S, F330A/S, and F200A/S all had the same ATP sensitivities as the wild-type P2X 4 R (Fig. 2b, Table 1 ), two potential factors likely contributed to the prolonged or reduced decay time of the current during the washout of the agonist: (1) the mutant changed the IVM-binding properties and (2) the mutant changed the signal transduction mechanism by which bound IVM altered channel gating sensitivity to ATP. The concentration-response relationship for the effect of IVM on current reflected IVM potency for the receptor; the potency of IVM was a combined measure of the ability of IVM to bind to the receptor (affinity) and the subsequent functional opening of channel gating induced by agonist [23] . We respectively tested the EC 50 of IVM on current amplitude and deactivation time activated by 10 μM ATP to evaluate the IVM-binding properties for receptor. Activated by ATP, the EC 50 of IVM on current amplitude of F200A/S (EC 50 =0.02±0.01/0.03±0.02 μM) leftward shifted while Y195A/S(EC 50 =0.78±0.11/0.82± 0.23 μM) rightward shifted compared with wild type (EC 50 =0.23±0.05 μM), and F330A/S (EC 50 =0.55±0.22/ 0.63±0.32 μM) showed comparable EC 50 to wild type (Fig. 4c, (Fig. 4b, Table 2 ). As shown in Fig. 4 , the IVM potency of the mutants and wild type did not change in parallel with the deactivation time. Obviously, the changed deactivation kinetics is not correlated with IVM-binding properties and reflects a change in the ability of bound IVM to alter gating function. Taken together, these results provide further evidence that bulky side chains within the linker regions are critical to channel gating.
Discussion
The current study sought to investigate the influence on channel gating of several conserved aromatic side chain residues located near the lateral fenestrations of P2X 4 R. We chose these residues because the positions they occupy also serve as part of the linker regions connecting the ATP-binding ectodomain of P2X 4 R with the pore-forming transmembrane domain. Zemkova reported the residues above TM1 were predominantly responsible for ion uptake into the extracellular vestibule lumen, whereas TM2 predominantly facilitated access to gate and permeation [25] . Molecular simulations were consistent with the prediction that the structure of these domains was important for conveying the conformational change caused by ATP binding to the gate-forming transmembrane helixes [26] . We report two principal findings. First, mutation of three residues, Tyr 54 , Phe
198
, and Trp
259
, produced mutants that expressed normally in the plasma membrane of transfected HEK293 cells but that were unresponsive to ATP concentrations as high as 1-3 mM. Second, mutation of four of the amino acids, Tyr (Fig. 1b) . For P2XR, agonist-induced rotation of the propeller-head domain of the receptor, sliding of adjacent subunits leading to restricted access to the upper vestibule, movement in the ion-conducting lateral portals, and gating of the channel pore have been demonstrated [27] .
Recently , which substantially impaired protein trafficking, these mutants were expressed in the plasma membrane of transfected HEK293 cells, and partial function could be recovered by IVM-mediated sensitization. Consistent with this previous work, we too observed that substitution of Tyr 54 yielded a non-functional receptor that was nevertheless expressed in the plasma membrane, although, in our hands, we were not able to recover function with IVM. Mutation of Tyr 55 of the rat P2X 2 R, which is analogous to Tyr 54 in P2X 4 R, has also been reported to yield nonfunctional receptors [29] .
We identified two additional aromatic side chains within the linker regions of P2X 4 R, Phe , this appeared to be due to an impairment of channel gating, and our data for this position in P2X 4 R supported this [23] . Indeed, we were able to Each receptor was examined in 4 to 15 cells in the presence (+IVM) or absence (−IVM) of 3 μM IVM, and the number of cells studied is given by n NF non-functional mutants, ND non-determined mutants a Mutant did not show function when the ATP concentration was increased to 3 mM b ATP (1-3 mM) was used to estimate I max in the absence of IVM *P<0.05, **P<0.01, or ***P<0.001, respectively, denote significant differences from WT or WT with IVM Fig. 3 The characterization of the substitution-deficient mutants of P2X 4 R. Each receptor was examined in five to ten cells in the presence IVM, and the number of cells studied is given by n are denoted with*P<0.05, or **P<0.01, respectively, denote significant differences from WT with IVM show in this paper that the ATP-gated current functionality of Phe 198 mutants could be recovered in IVM. In contrast to our immunofluorescence data for P2X 4 R-W259A, the analogous mutation in P2X 1 yielded receptors that were not functionally expressed in the plasma membrane [23] , and Nakazawa reported an aromatic ring with a hydroxyl group was necessary exactly at position 256 for P2X 2 R activation [30] . We reported here that volume was critical for the linker region residues contributing to the receptor function. (Fig. 5a ). As shown in Fig. 5b , Arg 203 was a critical residue for ATP-binding or channel-gating; this residue was involved in Fig. 4 The characterization of the substitution-normal mutants of P2X 4 R. a Example records of 10 μM ATP-induced currents in the presence of 3 μM IVM for the Y195A/S, F200A/S, and F330A/S mutants. b Concentration-response curves of IVM deactivation for the WT (n=10), Y195A (n=6), F200A (n=7), and F330A (n=5) receptor. c Concentration-response curves of IVM potentiation for the WT (n=10), Y195A (n=6), F200A (n=7), and F330A (n=5) receptor , produced functional receptors with normal ATP EC 50 values. Whereas the current profiles for F200A/S and F330A/S mutants were similar to wild type, the time course for current deactivation through Y195A/S mutants was significantly prolonged, possibly indicative of gating effects (Fig. 2a, Table 1 ). Furthermore, substitution of these residues was found to have a more nuanced impact on channel gating largely by altering the sensitivity of P2X 4 R to allosteric modulation by IVM. IVM is known to modulate P2X 4 R function in two specific ways [13] , possibly as a result of IVM interacting with two independent high-and low-affinity sites [33] . The high affinity effect of IVM is manifest as a potentiation in the amplitude of the ATP-gated current, whereas the low affinity effect is manifest as a prolongation of the time course for current deactivation upon ATP washout. Zemkova regarded the two different effects as IVM had distinct effects on opening and dilation of the channel pore, the first accounting for increased peak current amplitude and the latter correlating with changes in the EC 50 and kinetics of deactivation [34] . We had reservations because Khakh concluded that IVM did not change the open state of P2X 4 R [13] . Previous work on understanding how IVM facilitates the function of P2X 4 R has strongly favored a role for the TM domains in forming the binding sites for IVM, which makes sense given the propensity of this drug to partition into the lipid bilayer [24, 31, 35] . Single-channel analysis revealed that IVM binding altered gating by stabilizing the open conformation of the channel, thereby increasing open probability in the presence of ATP [33] . We observed that alanine and serine mutations introduced at four positions, Tyr In the case of Y195A/S, the fold increase in time course of current deactivation in the presence of IVM was reduced relative to wild type, although this was likely due to the fact that this mutation increased the deactivation time-course of ATPcurrents in the absence of IVM, thus potentially decreasing the fold-range over which IVM exerted an effect. Mutation of Phe 330 substantially augmented the effect of IVM on current deactivation, whereas mutation of residues, Phe 198 and Phe
200
, significantly attenuated this aspect of IVM sensitivity. Consistent with these changes likely not affecting IVM binding to the low affinity site per se, the half-maximal concentrations of IVM required to influence either ATP-gated current deactivation were not substantially different for the mutants compared to wild-type P2X 4 R. Thus, we believe that, while IVM likely binds the TM domains, its impact on ATP gating is in part determined by critical signal transduction residues in the linker regions connecting the ligand-binding and poreforming domains.
In summary, we present data supporting an important signal transduction/gating role for conserved aromatic residues located within regions of peptide linking the ATP-binding ectodomain of P2X 4 R to its pore-forming transmembrane domain. In addition to being important for normal ATP gating of P2X 4 R, our data suggest that these positions also influence the mechanism by which bound IVM allosterically modulates the ability for ATP to induce the necessary conformational changes associated with channel opening.
